Found 1,117 investors
MBC BioLabs
India
QB3@953 is a biotech incubator based in San Francisco, California. The firm provides incubator facilities which allow life science startups to progress at lightening speed, making a huge impact on the life-science ecosystem of the Bay Area.
Accelerator
Incubator
McKenny-McFarlane Capital
Cyprus
McKenny-McFarlane Capital is a private equity firm based in Limassol, Cyprus. The firm prefers to make investments in artificial intelligence, agriculture, cleantech, food tech, fintech, software-as-a-service, digital health, biotechnology, energy, and cleantech sectors.
Private Equity Firm
MDS Proteomics
Canada
MDS Proteomics was a venture capital firm based in Toronto. The firm preferred to invest in the biotechnology sector.
Venture Capital
Medicxi
United Kingdom
Founded in 2016, Medicxi is a venture capital firm based in London, United Kingdom. The firm prefers to invest in the healthcare, academia, biotech, and pharmaceutical sectors.
Venture Capital
MedImmune Ventures
Gaithersburg, Maryland, United States
MedImmune Ventures invests in early to late stage, public and private biotechnology companies.
Biotechnology
Financial Services
Venture Capital
Corporate Venture Capital
MedInnovate
United Kingdom
Founded in 2005, MedInnovate is a venture capital investment firm based in Hindhead, United Kingdom . The firm seeks to invest in companies operating in the healthcare, medicine, life sciences, pharmaceuticals and biotechnology sectors.
Venture Capital
Megafinance Partners
United States
Dr. Elliot Menschik serves as Chief Digital Officer at Resilience. He is also an Angel Investor. He served as Global Head, Industries + Technologies at Amazon Web Services. He is an Angel Investor. Previously, he served as a Managing Partner at DreamIt Ventures. He also served as Advisor at Lucidity Health. He is a physician/engineer/hacker turned serial entrepreneur and investor. He is a managing director of DreamIt Health, a program that invests in and accelerates the development of pre-seed healthtech ideas/teams/companies. He is a co-founder of Venturef0rth, a campus in Philadelphia for tech startups and an entity dedicated to doing whatever it takes to make it easier for early-stage companies to succeed. He also serves on the Penn faculty where he teaches a crash course in entrepreneurship for engineers and scientists aspiring to create companies that take their tech to market. Elliot was previously the founder and CEO of HxTechnologies, a pioneer in health information exchange which he sold to MEDecision in May 2009. Following the acquisition, he served as General Manager at MEDecision with responsibility for building new lines of business around health information exchange (HIE), electronic health record (EHR), personal health record (PHR) and telehealth products and services. On the academic side, Elliot is the author and inventor of multiple patents and patents pending. He's been an oft-invited speaker on the subject of imaging and health information exchange and is the author of numerous peer-reviewed papers ranging from medical informatics to computational neuroscience. He's been the principal investigator for a number of grants from the National Institutes of Health that funded HxTechnologies in its earliest days and has also led research on the economics of fragmented healthcare delivery nationwide. An NIH Fellow in the Medical Scientist Training Program, Elliot received an MD and PhD in Neuroscience from the University of Pennsylvania School of Medicine following his work on memory function and Alzheimer's disease developing and exploring massively-parallel computer models of the brain. He holds MSE and BSEE degrees in Electrical and Computer Engineering from the Johns Hopkins University following work on microchip design.
Individual/Angel
Melinda Rogers-Hixon
United States
Mr. Willie Quinn serves as Angel Investor at Willie Quinn. Mr. Willie Quinn Co-Founded and served as Chief Executive Officer at Bullet Biotechnology. He served as a Board Member at Neurogastrx. He co-founded and served as Board Member at Midnight Pharma. Prior to founding Bullet Bio, Willie was one of the first employees at Jazz Pharmaceuticals, where he worked for more than 8 years. As head of Corporate Development, his role included strategy development and execution, helping Jazz transform from a raw startup to a profitable, public specialty pharma company. Before Jazz, Willie was CFO and COO at Novation Biosciences, a biotech software company acquired by Agilent Technologies. Willie received an MBA, an MA, and a BA from Stanford University.
Individual/Angel
Melt Ventures
Australia
Founded in 2021, Melt Ventures is a Venture Capital firm based in Newcastle West, Australia. The firm prefers to invest in energy, cleantech, agriculture, IoT, and advanced manufacturing sectors operating in Australia.
Venture Capital
Meneldor
The Netherlands
Meneldor is a venture capital firm based in Druten, Netherlands. The firm focuses on early stage biotech and pharma companies which re-develop (New) Bio or Chemical Molecular Entities, that have technology with strong IP, address significant unmet medical needs.
Venture Capital
MeOhr Ventures
Israel
MeOhr Ventures is an early-stage venture capital firm based in Haifa, Israel. The firm prefers to make investments in the life-science and biotech opportunities.
Venture Capital
Mesa Verde Venture Partners
San Diego, California, United States
Mesa Verde Venture Partners focuses on investing in a diversified portfolio of early-stage biotechnology and medical technology companies.
Finance
Financial Exchanges
Financial Services
Micro VC
M. Glover Capital
United Kingdom
Mr. David Murray serves as Managing Director at Murray Capital. He is also an Angel Investor. David leads the team and runs the office at Murray Capital Group and is a second generation family member. He holds a BA degree in Business Management from Heriot Watt University, and has attended the Program for Management Development (PMD) at Harvard Business School and the Corporate Finance program from London Business School. David has previously worked for IMG in the Far East and Bank of Scotland (Corporate Division). David has been involved with a number of successful and high profile transactions. He holds non-executive directorships on the boards of various portfolio and family owned companies. David is also a past Chairman of the Institute of Family Business in Scotland and a member of the YPO Scotland Chapter.
Individual/Angel
MI-12 Ventures
United States
MI-12 Ventures is an angel group with a network of accredited investors. It does venture investments with an emphasis on the healthcare, medical device, biotechnology and digital health sectors. The firm is based in York, Pennsylvania and was founded in 2014.
Angel Group
Michael Bronfein
United States
Mr. Chris DiBona serves as Director of Open Source, Making & Science at Alphabet. He serves as Advisor at Metabiota. He also served as Advisor at GV. His team oversees license compliance and supports the open source developer community through programs such as the Google Summer of Code and through the release of open source software projects and patches. In the public sector space, Chris looks after Google Moderator and Google Elections. Chris is an internationally known advocate of open source software and related methodologies. He occasionally appears on the This Week in Tech and theThis Week in Google podcasts. He is a visiting scholar at the MIT Sloan School of Management and has a masters in software engineering from Carnegie Mellon University. Additionally, he serves on a number of technical advisory boards. Before joining Google, Chris was an editor and author for the website Slashdot.org. Additionally, he co-edited the award-winning essay compilations Open Sourcesand Open Sources 2.0.
Individual/Angel
Michael Hool
United States
Mr. Jonathan Hirsch Co-Founded and served as Board Member at Syapse. He is also an Angel Investor. Hirsch also serves as an Advisor at Biocogniv, Osmind and Advisor, Healthcare at Tau Ventures. He is a Co-Founder of Synapticure. Earlier in his career, Jonathan worked in Neuroscience Commercial Development at Abbott Laboratories, where he developed strategies to fund drug development through partnerships and private equity financing. While at the University of Chicago, Jonathan served as the Business Development Manager for three startup biotechnology companies, securing successful partnerships with commercial and government entities. His research at the Center for Molecular Neurobiology at the University of Chicago helped establish the effect of exercise on promoting hippocampal neurogenesis and combating Alzheimer's disease. Jonathan received an M.S. in Neuroscience from Stanford University and an A.B. in Biology and Political Philosophy from the University of Chicago.
Individual/Angel
Michael Speiser
Canada
The Eureka Project helped technology companies accelerate their growth by increasing their sales. The firm preferred to invest in the information and communications, engineering and advanced materials, health and biotechnology, environmental solutions, nutritional and agricultural sciences sectors. The firm is Out of Business.
Accelerator
Incubator
Michael Watson
Saint-didier-au-mont-d'or, Rhone-Alpes, France
He is an experienced Executive Committee member of successful biotech and global commercial vaccines companies in UK, France and the USA for...
Individual/Angel
Michael Winnick
United States
Mr. Timothy Curran serves as Chief Executive Officer, Executive Managing Director and Board Director at Building Engines. He is the former CEO of Sample6, a biotech company bringing ultra-rapid pathogenic bacteria detection products to food safety and other markets. He also serves on the board of several companies in addition to Building Engines, including Repsly Inc., Powerhouse Dynamics, and arcbazar.com. He is also a partner at CommonAngels Ventures. Prior to Sample6, he served as CEO of Vela Systems, a field management software company in the Architecture, Engineering and Construction industry, which was acquired by Autodesk (ADSK) in June 2012. Prior to joining Vela, he served as CEO of Eleven Technology, the leader in next-generation mobile field applications for the retail & consumer goods industry. Eleven was successfully acquired by Trimble Navigation (TRMB) in April 2006. Prior to Eleven, he spent five years as the number two executive of I-many, Inc., an enterprise contract management software company that grew from $6MM to $60MM in sales and went public during his tenure. His roles at I-many included EVP of Sales and Marketing and EVP of Corporate Development. Prior to I-many, he spent eight years with Accenture and a year with EMC Corporation. He holds a BS in Chemical Engineering from Case Western Reserve University and an MBA from the University of Chicago.
Individual/Angel
Mike Elliott
Charlotte, North Carolina, United States
Mike Elliott joined NMP in 2005 with 21 years of successful venture capital investment experience. Previously, Mike spent eight years as a M...
Investment Partner
Showing 721 to
740 of
1,117 results